vs
Side-by-side financial comparison of Nextpower Inc. (NXT) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Nextpower Inc. is the larger business by last-quarter revenue ($909.4M vs $622.0M, roughly 1.5× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 14.4%, a 20.0% gap on every dollar of revenue. On growth, Nextpower Inc. posted the faster year-over-year revenue change (33.9% vs 4.8%). Over the past eight quarters, Nextpower Inc.'s revenue compounded faster (11.1% CAGR vs 4.6%).
Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
NXT vs RPRX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $909.4M | $622.0M |
| Net Profit | $131.2M | $214.2M |
| Gross Margin | 31.7% | — |
| Operating Margin | 19.4% | 62.4% |
| Net Margin | 14.4% | 34.4% |
| Revenue YoY | 33.9% | 4.8% |
| Net Profit YoY | 13.8% | 2.9% |
| EPS (diluted) | $0.85 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $909.4M | $622.0M | ||
| Q3 25 | $905.3M | $609.3M | ||
| Q2 25 | $864.3M | $578.7M | ||
| Q1 25 | $924.3M | $568.2M | ||
| Q4 24 | $679.4M | $593.6M | ||
| Q3 24 | $635.6M | $564.7M | ||
| Q2 24 | $719.9M | $537.3M | ||
| Q1 24 | $736.5M | $568.0M |
| Q4 25 | $131.2M | $214.2M | ||
| Q3 25 | $146.9M | $288.2M | ||
| Q2 25 | $157.2M | $30.2M | ||
| Q1 25 | $156.8M | $238.3M | ||
| Q4 24 | $115.3M | $208.2M | ||
| Q3 24 | $115.4M | $544.0M | ||
| Q2 24 | $121.7M | $102.0M | ||
| Q1 24 | $205.2M | $4.8M |
| Q4 25 | 31.7% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.6% | — | ||
| Q1 25 | 33.1% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.4% | — | ||
| Q2 24 | 33.0% | — | ||
| Q1 24 | 46.2% | — |
| Q4 25 | 19.4% | 62.4% | ||
| Q3 25 | 20.0% | 70.1% | ||
| Q2 25 | 21.5% | 36.3% | ||
| Q1 25 | 21.1% | 94.0% | ||
| Q4 24 | 22.1% | 60.9% | ||
| Q3 24 | 21.0% | — | ||
| Q2 24 | 22.2% | 50.2% | ||
| Q1 24 | 36.8% | -13.0% |
| Q4 25 | 14.4% | 34.4% | ||
| Q3 25 | 16.2% | 47.3% | ||
| Q2 25 | 18.2% | 5.2% | ||
| Q1 25 | 17.0% | 41.9% | ||
| Q4 24 | 17.0% | 35.1% | ||
| Q3 24 | 18.2% | 96.3% | ||
| Q2 24 | 16.9% | 19.0% | ||
| Q1 24 | 27.9% | 0.8% |
| Q4 25 | $0.85 | $0.49 | ||
| Q3 25 | $0.97 | $0.67 | ||
| Q2 25 | $1.04 | $0.07 | ||
| Q1 25 | $1.05 | $0.55 | ||
| Q4 24 | $0.79 | $0.46 | ||
| Q3 24 | $0.79 | $1.21 | ||
| Q2 24 | $0.84 | $0.23 | ||
| Q1 24 | $1.52 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $952.6M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $2.2B | $9.7B |
| Total Assets | $3.8B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $952.6M | $618.7M | ||
| Q3 25 | $845.3M | $938.9M | ||
| Q2 25 | $743.4M | $631.9M | ||
| Q1 25 | $766.1M | $1.1B | ||
| Q4 24 | $693.5M | $929.0M | ||
| Q3 24 | $561.9M | $950.1M | ||
| Q2 24 | $471.9M | $1.8B | ||
| Q1 24 | $474.1M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $2.2B | $9.7B | ||
| Q3 25 | $2.0B | $9.6B | ||
| Q2 25 | $1.8B | $9.5B | ||
| Q1 25 | $1.6B | $9.8B | ||
| Q4 24 | $1.4B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.1B | $9.8B | ||
| Q1 24 | $961.0M | $9.9B |
| Q4 25 | $3.8B | $19.6B | ||
| Q3 25 | $3.7B | $19.3B | ||
| Q2 25 | $3.4B | $18.3B | ||
| Q1 25 | $3.2B | $17.6B | ||
| Q4 24 | $3.0B | $18.2B | ||
| Q3 24 | $2.8B | $18.0B | ||
| Q2 24 | $2.6B | $17.7B | ||
| Q1 24 | $2.5B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.3M | $827.1M |
| Free Cash FlowOCF − Capex | $118.5M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | 0.94× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $587.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.3M | $827.1M | ||
| Q3 25 | $186.9M | $702.6M | ||
| Q2 25 | $81.3M | $364.0M | ||
| Q1 25 | $237.3M | $596.1M | ||
| Q4 24 | $143.8M | $742.5M | ||
| Q3 24 | $153.8M | $703.6M | ||
| Q2 24 | $120.8M | $658.2M | ||
| Q1 24 | $111.5M | $664.6M |
| Q4 25 | $118.5M | — | ||
| Q3 25 | $171.4M | — | ||
| Q2 25 | $70.1M | — | ||
| Q1 25 | $227.2M | — | ||
| Q4 24 | $134.9M | — | ||
| Q3 24 | $141.8M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $109.2M | — |
| Q4 25 | 13.0% | — | ||
| Q3 25 | 18.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 16.4% | — | ||
| Q1 24 | 14.8% | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 0.94× | 3.86× | ||
| Q3 25 | 1.27× | 2.44× | ||
| Q2 25 | 0.52× | 12.06× | ||
| Q1 25 | 1.51× | 2.50× | ||
| Q4 24 | 1.25× | 3.57× | ||
| Q3 24 | 1.33× | 1.29× | ||
| Q2 24 | 0.99× | 6.45× | ||
| Q1 24 | 0.54× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
